Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to investigate the clinical efficacy and associated immune and inflammatory mechanisms in patients with malignant tumors of spleen deficiency and dampness resistance type, by applying pricking therapy and wheat grain moxibustion on the back shu points or positive reaction points.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| pricking therapy and wheat grain moxibustion combined with chemotherapy | Experimental | pricking therapy and wheat grain moxibustion on the back shu points or positive reaction points combined with chemotherapy |
|
| chemotherapy | Active Comparator | Conventional chemotherapy regimen |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pricking therapy and wheat grain moxibustion | Other | pricking therapy and wheat grain moxibustion on the back shu points or positive reaction points |
|
| Measure | Description | Time Frame |
|---|---|---|
| Progression-Free Survival (ORR) | Evaluate the objective response rate (ORR) of subjects based on RECIST V1.1 | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| progression free survival (PFS), | Evaluate subjects' progression free survival (PFS), overall survival (OS), and duration of remission (DOR) based on RECIST V1.1 | 5 years |
| overall survival (OS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Qingtao Ni | Contact | 18852656280 | nqt1990@126.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Qingtao Ni | Recruiting | Taizhou | Jiangsu | 225300 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate subjects' overall survival (OS) based on RECIST V1.1
| 5 years |
| duration of remission (DOR) | Evaluate subjects' duration of remission (DOR) based on RECIST V1.1 | 5 years |
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided